Drug intelligence / Profile preview

ganoderic acid DM

Development stage
Preclinical
Modality
Classical Binding Small Molecules → Small Molecules
Administration
In Vitro (no Established Clinical Route; Primarily Laboratory/experimental Use)
01

Overview

Ganoderic acid DM is a triterpenoid compound isolated from the fruiting body of the medicinal mushroom *Ganoderma lucidum* (Lingzhi). It is a bioactive natural product classified as a lanostane-type triterpenoid. Ganoderic acid DM possesses **antiandrogenic, anti-osteoclastogenic, anti-cancer, and pro-apoptotic activity**. Mechanistically, it inhibits key mediators including c-Fos and NFATc1, consequently suppressing dendritic cell-specific transmembrane protein (DC-STAMP) and reducing osteoclast fusion. It also acts as an inhibitor of androgen receptor signaling and has demonstrated toxicity against both androgen-dependent and -independent prostate cancer cells, making it a potential agent for advanced prostate cancer. Recent studies highlight its **potential in breast cancer by inhibiting PIK3CA and related pathways, suggesting cell cycle arrest, apoptosis induction, and reduced cancer cell growth**. Additional inhibitory effects on 5α-reductase, PARP, CDK, NF-κB, and TNF-α have been reported, indicating broad implications for cancer therapy and immunomodulation[1][3][5][7][9].

Other names
ganoderate DM
02

Targets

PIK3CA (Phosphoinositide 3-kinase alpha)HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)CDK (CDK family)PARP (Poly(ADP-ribose) polymerase)TNFA (Tumor necrosis factor alpha (soluble))SRD5A (Steroid 5-alpha-reductase)NF-κBAR (Adrenergic receptors)

Beyond the preview

Go deeper on ganoderic acid DM.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ganoderic acid DM.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call